These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 33968608)

  • 41. Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in a University Student Population.
    Rennert L; McMahan C
    Clin Infect Dis; 2022 Mar; 74(4):719-722. PubMed ID: 33993225
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural Modeling of the SARS-CoV-2 Spike/Human ACE2 Complex Interface can Identify High-Affinity Variants Associated with Increased Transmissibility.
    Gan HH; Twaddle A; Marchand B; Gunsalus KC
    J Mol Biol; 2021 Jul; 433(15):167051. PubMed ID: 33992693
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-COVID 19 neurological syndrome: Implications for sequelae's treatment.
    Camargo-Martínez W; Lozada-Martínez I; Escobar-Collazos A; Navarro-Coronado A; Moscote-Salazar L; Pacheco-Hernández A; Janjua T; Bosque-Varela P
    J Clin Neurosci; 2021 Jun; 88():219-225. PubMed ID: 33992187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage.
    Colson P; Levasseur A; Delerce J; Pinault L; Dudouet P; Devaux C; Fournier PE; La Scola B; Lagier JC; Raoult D
    Clin Microbiol Infect; 2021 Sep; 27(9):1352.e1-1352.e5. PubMed ID: 33991677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epitope profiling reveals binding signatures of SARS-CoV-2 immune response in natural infection and cross-reactivity with endemic human CoVs.
    Stoddard CI; Galloway J; Chu HY; Shipley MM; Sung K; Itell HL; Wolf CR; Logue JK; Magedson A; Garrett ME; Crawford KHD; Laserson U; Matsen FA; Overbaugh J
    Cell Rep; 2021 May; 35(8):109164. PubMed ID: 33991511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dynamics of B cell repertoires and emergence of cross-reactive responses in patients with different severities of COVID-19.
    Montague Z; Lv H; Otwinowski J; DeWitt WS; Isacchini G; Yip GK; Ng WW; Tsang OT; Yuan M; Liu H; Wilson IA; Peiris JSM; Wu NC; Nourmohammad A; Mok CKP
    Cell Rep; 2021 May; 35(8):109173. PubMed ID: 33991510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhaled budesonide for early treatment of COVID-19.
    Zeitlinger M; Idzko M
    Lancet Respir Med; 2021 Jul; 9(7):e59. PubMed ID: 33991506
    [No Abstract]   [Full Text] [Related]  

  • 48. Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
    Deng X; Garcia-Knight MA; Khalid MM; Servellita V; Wang C; Morris MK; Sotomayor-González A; Glasner DR; Reyes KR; Gliwa AS; Reddy NP; Sanchez San Martin C; Federman S; Cheng J; Balcerek J; Taylor J; Streithorst JA; Miller S; Sreekumar B; Chen PY; Schulze-Gahmen U; Taha TY; Hayashi JM; Simoneau CR; Kumar GR; McMahon S; Lidsky PV; Xiao Y; Hemarajata P; Green NM; Espinosa A; Kath C; Haw M; Bell J; Hacker JK; Hanson C; Wadford DA; Anaya C; Ferguson D; Frankino PA; Shivram H; Lareau LF; Wyman SK; Ott M; Andino R; Chiu CY
    Cell; 2021 Jun; 184(13):3426-3437.e8. PubMed ID: 33991487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Laboratory testing for ADAMTS13: Utility for TTP diagnosis/exclusion and beyond.
    Favaloro EJ; Pasalic L; Henry B; Lippi G
    Am J Hematol; 2021 Aug; 96(8):1049-1055. PubMed ID: 33991361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
    Coperchini F; Chiovato L; Rotondi M
    Front Immunol; 2021; 12():668507. PubMed ID: 33981314
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).
    Román GC; Gracia F; Torres A; Palacios A; Gracia K; Harris D
    Front Immunol; 2021; 12():653786. PubMed ID: 33981305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glucose-lowering treatments and COVID-19 mortality in T2DM.
    Hadjadj S; Wargny M
    Nat Rev Endocrinol; 2021 Jul; 17(7):387-388. PubMed ID: 33981029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The epidemicity index of recurrent SARS-CoV-2 infections.
    Mari L; Casagrandi R; Bertuzzo E; Pasetto D; Miccoli S; Rinaldo A; Gatto M
    Nat Commun; 2021 May; 12(1):2752. PubMed ID: 33980858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic.
    Modi C; Böhm V; Ferraro S; Stein G; Seljak U
    Nat Commun; 2021 May; 12(1):2729. PubMed ID: 33980836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the SARS-CoV-2 Neutralization Potential of COVID-19-Convalescent Donors.
    Jahrsdörfer B; Groß R; Seidel A; Wettstein L; Ludwig C; Schwarz T; Körper S; Rojewski M; Lotfi R; Weinstock C; Seifried E; Corman VM; Drosten C; Münch J; Schrezenmeier H
    J Immunol; 2021 Jun; 206(11):2614-2622. PubMed ID: 33980583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of T Cell Epitopes in the Spike Glycoprotein of Severe Acute Respiratory Syndrome Coronavirus 2 in Rhesus Macaques.
    Liu X; Li Y; Xiao H; Bi Y; Gong Y; Hu Z; Zeng Y; Sun M; He Z; Lu S; Li Q; Cun W
    J Immunol; 2021 Jun; 206(11):2527-2535. PubMed ID: 33980582
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis.
    Finkel Y; Gluck A; Nachshon A; Winkler R; Fisher T; Rozman B; Mizrahi O; Lubelsky Y; Zuckerman B; Slobodin B; Yahalom-Ronen Y; Tamir H; Ulitsky I; Israely T; Paran N; Schwartz M; Stern-Ginossar N
    Nature; 2021 Jun; 594(7862):240-245. PubMed ID: 33979833
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythroid precursors and progenitors suppress adaptive immunity and get invaded by SARS-CoV-2.
    Shahbaz S; Xu L; Osman M; Sligl W; Shields J; Joyce M; Tyrrell DL; Oyegbami O; Elahi S
    Stem Cell Reports; 2021 May; 16(5):1165-1181. PubMed ID: 33979601
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Possible Human-to-Dog Transmission of SARS-CoV-2, Italy, 2020.
    Decaro N; Vaccari G; Lorusso A; Lorusso E; De Sabato L; Patterson EI; Di Bartolo I; Hughes GL; Teodori L; Desario C; Colitti B; Ricci D; Buonavoglia D; Rosati S; Martella V; Cammà C; Agrimi U; Elia G
    Emerg Infect Dis; 2021; 27(7):1981-1984. PubMed ID: 33979566
    [TBL] [Abstract][Full Text] [Related]  

  • 60. BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants.
    Liu Y; Liu J; Xia H; Zhang X; Zou J; Fontes-Garfias CR; Weaver SC; Swanson KA; Cai H; Sarkar R; Chen W; Cutler M; Cooper D; Muik A; Sahin U; Jansen KU; Xie X; Dormitzer PR; Shi PY
    N Engl J Med; 2021 Jul; 385(5):472-474. PubMed ID: 33979486
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.